Thrombocytopenia in HIV infection: Impairment of platelet formation and loss correlates with increased c-Mpl and ligand thrombopoietin expression

Current HIV Research

Volumn 4, Issue 1, 2006, Pages 107-116

  Sundell, I Birgitta ^a,b   Koka, Prasad S ^a  

^a TORREY PINES INSTITUTE FOR MOLECULAR STUDIES   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Activation; Aggregation; Baboon; c Mpl; Chimpanzee; HIV; Human; Megakaryocyte; Platelet; Thrombocytopenia; Thrombopoietin

Indexed keywords

ADENOSINE DIPHOSPHATE; ANTIRETROVIRUS AGENT; RECOMBINANT MEGAKARYOCYTE GROWTH AND DEVELOPMENT FACTOR; THROMBOPOIETIN; THROMBOPOIETIN RECEPTOR; CYTOKINE RECEPTOR; MACROGOL DERIVATIVE; MPL PROTEIN, HUMAN; ONCOPROTEIN; POLYETHYLENE GLYCOL RECOMBINANT HUMAN MEGAKARYOCYTE GROWTH AND DEVELOPMENT FACTOR; POLYETHYLENE GLYCOL-RECOMBINANT HUMAN MEGAKARYOCYTE GROWTH AND DEVELOPMENT FACTOR; RECOMBINANT PROTEIN;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; CLINICAL ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG MECHANISM; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; PATHOGENESIS; PROTEIN EXPRESSION; PROTEIN METABOLISM; REVIEW; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; THROMBOCYTOPENIA; THROMBOCYTOPOIESIS; ANIMAL; ARTICLE; IMMUNOLOGY; METABOLISM; PAN TROGLODYTES; PAPIO; PATHOPHYSIOLOGY; PHYSIOLOGY; THROMBOCYTE;

ADULT; ANIMALS; BLOOD PLATELETS; FEMALE; HIV INFECTIONS; HUMANS; MALE; PAN TROGLODYTES; PAPIO; PLATELET COUNT; POLYETHYLENE GLYCOLS; PROTO-ONCOGENE PROTEINS; RECEPTORS, CYTOKINE; RECEPTORS, THROMBOPOIETIN; RECOMBINANT PROTEINS; THROMBOCYTOPENIA; THROMBOPOIETIN;

EID: 33644888311     PISSN: 1570162X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157016206775197646     Document Type: Review

References (30)

1. Bartley TD, Bogenberger J, Hunt P, Li Y-S, Lu HS, Martin F, Chang M-S, Samal B, Nichol JL, Swift S, Johnson MJ, Hsu R-Y, Parker VP, Suggs S, Skrine JD, Merewether LA, Clogston C, Hsu E, Holkom NM, Hornkohl A, Choi E, Pangelinan M, Sun Y, Mar V, McNinch J, Simonet L, Jacobsen F, Xie C, Sutter J, Chute H, Basu R, Selander L, Trollinger D, Sieu L, Padilla D, Trail G, Elliott G, Izumi R, Covey T, Crouse J, Garcia A, Xu W, Del Castillo J, Biron J, Cole S, Hu MC-T, Pacifici R, Ponting I, Saris C, Wen D, Yung YP, Lin H, Bosselman RA. (1994). Identification and cloning of a megakaryocyte growth and development factor that is a ligand for cytokine receptor Mpl. Cell. 77: 1117-1124.
2. Cadroy Y, Hanson SR, Kelly AB, Marzec UM, Evatt BL, Kunicki TJ, Montgomery RR, Harker LA. (1994). Relative antithrombotic effrects of monoclonal antibodies targeting different platelet glycoprotein-adhesive molecule interactions in non-human primates. Blood. 83: 3218-3224.
3. Chang MS, McNinch J, Basu R, Shutter J, Hsu RY, Perkins C, Mar V, Suggs S, Welcher A, Li L, Hsieng L, Bartley T, Hunt P, Martin F, Samal B, Bogenberger J. (1995). Cloning and characterization of the human megakaryocyte growth and development factor (MGDF) gene. Journal of Biological Chemistry. 270: 511-514.
4. Ciernik IF, Cone RW, Fehr J, Weber R. (1999). Impaired liver function and retroviral activity are risk factors contributing to HIV-associated thrombocytopenia. Swiss HIV Cohort, Study. AIDS. 13: 1913-1920.
5. Cole JL, Marzec UM, Gunthel CJ, Karpatkin S, Worford L, Sundell IB, Lennox JL, Nichol JL, Harker LA. (1998). Ineffective platelet production in thrombocytopenic human inummodeficency virus-infected patients. Blood. 91: 3239-3246.
6. Dahlen DD, Broudy VC, Drachman JG. (2003). Internalization of the thrombopoietin receptor is regulated by 2 cytoplasmic motifs. Blood. 102:102-108.
7. Espanol I, Muniz-Diaz E, Margall N, Rabella N, Sambeat MA, Hernandez A, Pujol-Moix N. (1999). Serum thrombopoietin levels in thrombocytopenic and non-thrombocytopenic patients with human immunodeficiency virus (HIV-1) infection. European Journal of Haematology. 63: 245-50.
8. Fultz PN, Mawle AC, Swenson RB, McClure HM. (1991). Prolonged CD4+ lymphocytopenia and thrombocytopenia in a chompanzee persistently infected with human immunodeficiency virus type 1. Journal of Infectious Diseases. 163: 441-447.
9. Hanson SR, Pareti FI, Ruggeri ZM, Kunicki TJ, Montgomery RR, Zimmerman TS, Harker LA. (1988). Effects of monoclonal antibodies against the platelet glycoprotein IIb/IIIa complex on thrombosis and hemostasis in the baboon. Journal of Clinical Investigation. 81: 149-158.
10. Harker LA, Marzec UM, Hunt P, Kelly AB, Tomer A, Chung E, Hanson SR, Stead RB. (1996). Dose-response effetcs of pegylated human megakaryocyte growth and development factor on platelet production and function in nonhuman primates. Blood. 88: 511-521.
11. Harker LA, Marzec UM, Kelly AB, Cheung E, Tomer A, Nichol JL, Hanson SR, Stead RB. (1997). Prevention of thrombocytopenia and neutropenia in a non-human primate model of marrow suppressive chemotherapy by combining pegylated recombinant human megakaryocyte growth and development factor and recombinant human granulocyte colony-stimulating factor. Blood. 89: 155-165.
12. Harker LA, Marzec UM, Novembre F, Sundell IB, Waller EK, Karpatkin S, McClure HM, Kelly AB, Stead RB. (1998). Treatment of thrombocytopenia in chimpanzees infected with human immunodeficiency virus by pegylated recombinant human megakaryocyte growth and development factor. Blood. 91: 4427-4433.
13. Harker LA, Roskos LK, Marzec UM, Carter RA, Cherry JK, Sundell B, Cheung EN, Terry D, Sheridan W. (2000). Effects of megakaryocyte growth and development factor on platelet production, platelet life span, and platelet function in healthy human volunteers. Blood. 95: 2514-2522.
14. Hecher B, Toselli P, Ravanat C, Gachet C, Ravid K. (2001). Mpl ligand increases P2Y1 receptor gene expression in megakaryocytes with no concomitant change in platelet response to ADP. Molecular Pharmacology. 60: 1112-1120.
15. Kaushansky K, Lok S, Holly RD, Broudy VC, Lin N, Bailey MC, Forstrom JW, Buddle MM, Oort PJ, Hagen FS, Roth GJ, Papayannopoulou T, Foster DC. (1994). Promotion of megakaryocyte progenitor expansion and differentiation by the c-Mpl ligand thrombopoietin. Nature. 369: 568-571.
16. Kelly AB, Marzec UM, Krupski W, Bass A, Cadroy Y, Hanson SR, Harker LA. (1991). Hirudin interruption of heparin-resistant arerial thrombus formation in baboons. Blood. 77: 1006-1012.
17. Koenig C, Sidhu GS, Schoentag RA. (1991). The platelet volume-number relationship in patients infected with the human immunodeficiency virus. American Journal of Clinical Pathology. 96: 500-503.
18. Koka PS, Fraser JK, Bryson Y, Bristol GC, Aldrovandi GM, Daar ES, Zack JA. (1998). Human immunodeficiency virus inhibits multilineage hematopoiesis in vivo. Journal of Virolology. 72: 5121-5127.
19. Koka PS, Kitchen CM, Reddy ST. (2004). Targeting c-Mpl for revival of human immunodeficiency virus type 1-induced hematopoietic inhibition when CD34+ progenitor cells are re-engrafted into a fresh stromal microenvironment in vivo. Journal of Virology. 78: 11385-11392.
20. Koka PS, Reddy ST. (2004). Cytopenias in HIV infection: Mechanisms and alleviation of hematopoietic inhibition. Current HIV research. 2: 275-282.
21. Li J, Xia Y, Kuter DJ. (1999). Interaction of thrombopoietin with the platelet c-mpl receptor in plasma: binding, internalization, stability and pharmacokinetics. British Journal of Haematology. 106: 345-356.
22. Li J, Xia Y, Kuter DJ. (2000). The platelet thrombopoietin receptor number and function are markedly decreased in patients with essential thrombocythaemia. British Journal of Haematology. 111: 943-953.
23. Moliterno AR, Williams DM, Gutierrez-Alamillo LI, Salvatori R, Ingersoll RG, Spivak JL. (2004). Mpl Baltimore: A thrombopoietin receptor polymorphism associated with thrombocytosis. Proceedings of National Academy of Sciences USA. 101: 11444-11447.
24. Rao AK, Goldberg RE, Walsh PN. (1984). Platelet coagulant activities in diabetes mellitus. Evidence for relationship between platelet coagulant hyperactivity and platelet volume. Journal of Laboratory Clinical Investigation. 103: 82-92.
25. Sharp DS, Bath PMW, Martin JF, Sweetnam PN. (1994). Platelet and erythrocyte volume and count; epidemiological predictors of impedance measured ADP-induced platelet aggregation in whole blood. Platelets. 5: 252-257.
26. Tomer A. (2004). Human marrow megakaryocyte differentiation: multiparameter correlative analysis identifies von Willebrand factor as a sensitive and distinctive marker for early (2N and 4N) megakaryocytes. Blood. 104: 2722-2727.
27. Ulich TR, del Castillo J, Senaldi G, Cheung E, Roskos L, Young J, Molineux G, Guo J, Schoemperlen J, Munyakazi L, Murphy-Filkins R, Tarpley JE, Toombs CF, Kaufman S, Yin S, Nelson AG, Nichol JL, Sheridan WP. (1999). The prolonged hematologic effects of a single injection of PEG-rHuMGDF in normal and thrombocytopenic mice. Experimental Hematology. 27: 117-130.
28. Wendling F, Maraskovsky E, Debili N, Florindo C, Teepe M, Titeux M, Methia N, Breton-Gorius J, Cosman D, Vainchenker W. (1994). c-Mpl ligand is a humoral regulator of megakaryopoiesis. Nature. 369: 571-574.
29. Zauli G, Catani L, Gibellini D, Re MC, Vianelli N, Colangeli V, Celeghini C, Capitani S, La Placa M. (1996). Impaired survival of bone marrow GPIIb/IIa+ megakaryocytic cells as an additional pathogenetic mechanism of HIV-1-related thrombocytopenia. British Journal of Haematology. 92: 711-717.
30. Zauli G, Re MC, Gugliotta L, Visani G, Vianelli N, Furlini G, La Placa M. (1991). Lack of compensatory megakaryopoiesis in HIV-1-seropositive thrombocytopenic individuals compared with immune thrombocytopenic purpura patients. AIDS. 5: 1345-1350.